LT99100A - Vandeninė suspensija, vartotina per nosį - Google Patents

Vandeninė suspensija, vartotina per nosį

Info

Publication number
LT99100A
LT99100A LT99-100A LT99100A LT99100A LT 99100 A LT99100 A LT 99100A LT 99100 A LT99100 A LT 99100A LT 99100 A LT99100 A LT 99100A
Authority
LT
Lithuania
Prior art keywords
aqueous suspension
nasal administration
nasal
administration
suspension
Prior art date
Application number
LT99-100A
Other languages
English (en)
Other versions
LT4677B (lt
Inventor
Koji Doi
Original Assignee
Bodor,Nicholas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bodor,Nicholas filed Critical Bodor,Nicholas
Publication of LT99100A publication Critical patent/LT99100A/lt
Publication of LT4677B publication Critical patent/LT4677B/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
LT99-100A 1997-01-16 1999-08-12 Vandeninė suspensija, vartotina per nosį LT4677B (lt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1966497 1997-01-16

Publications (2)

Publication Number Publication Date
LT99100A true LT99100A (lt) 2000-02-25
LT4677B LT4677B (lt) 2000-07-25

Family

ID=12005518

Family Applications (1)

Application Number Title Priority Date Filing Date
LT99-100A LT4677B (lt) 1997-01-16 1999-08-12 Vandeninė suspensija, vartotina per nosį

Country Status (33)

Country Link
US (1) US6368616B1 (lt)
EP (1) EP0973501B1 (lt)
KR (1) KR100471708B1 (lt)
CN (1) CN1126535C (lt)
AR (1) AR011773A1 (lt)
AT (1) ATE249205T1 (lt)
AU (1) AU730953C (lt)
BR (1) BR9806771A (lt)
CA (1) CA2278025C (lt)
CZ (1) CZ294919B6 (lt)
DE (1) DE69818026T2 (lt)
DK (1) DK0973501T3 (lt)
EA (1) EA001775B1 (lt)
ES (1) ES2206880T3 (lt)
HK (1) HK1026138A1 (lt)
HU (1) HU226613B1 (lt)
ID (1) ID21892A (lt)
IL (1) IL130979A0 (lt)
LT (1) LT4677B (lt)
LV (1) LV12449B (lt)
MX (1) MXPA99006628A (lt)
NO (1) NO324619B1 (lt)
NZ (2) NZ509908A (lt)
PL (1) PL190753B1 (lt)
PT (1) PT973501E (lt)
RS (1) RS49701B (lt)
SI (1) SI20057A (lt)
SK (1) SK283164B6 (lt)
TR (1) TR199901663T2 (lt)
TW (1) TW503113B (lt)
UA (1) UA52722C2 (lt)
WO (1) WO1998031343A2 (lt)
ZA (1) ZA98303B (lt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI243687B (en) 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
US6428805B1 (en) * 1998-08-26 2002-08-06 Teijin Limited Powdery nasal compositions
DE19947235A1 (de) * 1999-09-30 2001-04-05 Asta Medica Ag Neue Kombination von Loteprednol und beta¶2¶-Adrenorezeptor-Agonisten
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
US6565832B1 (en) * 2000-01-31 2003-05-20 Schering-Plough Healthcare Products, Inc. Spray composition with reduced dripping
ATE526973T1 (de) * 2001-06-18 2011-10-15 Noven Pharma Verbesserte arzneimittelabgabe in transdermalen systemen
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
US8912174B2 (en) 2003-04-16 2014-12-16 Mylan Pharmaceuticals Inc. Formulations and methods for treating rhinosinusitis
US9808471B2 (en) * 2003-04-16 2017-11-07 Mylan Specialty Lp Nasal pharmaceutical formulations and methods of using the same
US7811606B2 (en) * 2003-04-16 2010-10-12 Dey, L.P. Nasal pharmaceutical formulations and methods of using the same
EP1658083B1 (en) * 2003-06-19 2007-08-08 BODOR, Nicholas S. Enhancement of activity and/or duration of action of selected anti-inflammatory steroids
DE602004025002D1 (de) 2003-06-19 2010-02-25 Nicholas S Bodor Steigerung der aktivität und/oder der wirkungsdauer weicher steroide mit anti-entzündungswirkung für topische oder lokale verabreichung
US20050095205A1 (en) * 2003-10-31 2005-05-05 Ramesh Krishnamoorthy Combination of loteprednol etabonate and tobramycin for topical ophthalmic use
CA2560824A1 (en) 2004-03-25 2005-10-13 Bausch & Lomb Incorporated Use of loteprednol etabonate for the treatment of dry eye
US20070099883A1 (en) * 2005-10-07 2007-05-03 Cheryl Lynn Calis Anhydrous mometasone furoate formulation
US20070110812A1 (en) * 2005-11-14 2007-05-17 Bausch & Lomb Incorporated Ophthalmic composition for dry eye therapy
US7691811B2 (en) * 2006-05-25 2010-04-06 Bodor Nicholas S Transporter-enhanced corticosteroid activity and methods and compositions for treating dry eye
US7687484B2 (en) * 2006-05-25 2010-03-30 Bodor Nicholas S Transporter enhanced corticosteroid activity
WO2012119261A1 (en) * 2011-03-10 2012-09-13 Biocia Inc. Enhanced artificial mucus composition comprising hyaluronan for the treatment of rhinitis
AU2012312816A1 (en) 2011-09-22 2014-04-24 Bausch & Lomb Incorporated Ophthalmic gel compositions
CN111050750A (zh) 2017-08-24 2020-04-21 诺沃挪第克公司 Glp-1组合物及其用途
CN115135305A (zh) 2020-02-18 2022-09-30 诺和诺德股份有限公司 药物制剂

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5540930A (en) * 1993-10-25 1996-07-30 Pharmos Corporation Suspension of loteprednol etabonate for ear, eye, or nose treatment
EP0709099A3 (en) 1994-09-28 1996-07-24 Senju Pharma Co Aqueous suspension for nasal administration containing cyclodextrin
KR100508227B1 (ko) 1997-03-14 2006-03-23 센주 세이야꾸 가부시키가이샤 로테프레드놀에타보네이트수성현탁액

Also Published As

Publication number Publication date
HK1026138A1 (en) 2000-12-08
ID21892A (id) 1999-08-05
KR20000070214A (ko) 2000-11-25
MXPA99006628A (es) 2005-01-10
EP0973501B1 (en) 2003-09-10
ZA98303B (en) 1998-07-20
HU226613B1 (en) 2009-04-28
NZ509908A (en) 2004-12-24
NZ336990A (en) 2001-03-30
LV12449A (lv) 2000-04-20
SI20057A (sl) 2000-04-30
CN1250370A (zh) 2000-04-12
TR199901663T2 (xx) 1999-09-21
DE69818026D1 (de) 2003-10-16
AU730953C (en) 2002-02-07
SK94899A3 (en) 2000-05-16
NO993453L (no) 1999-07-13
PT973501E (pt) 2004-02-27
ES2206880T3 (es) 2004-05-16
IL130979A0 (en) 2001-01-28
NO993453D0 (no) 1999-07-13
DK0973501T3 (da) 2004-01-19
CA2278025A1 (en) 1998-07-23
BR9806771A (pt) 2000-05-16
EP0973501A2 (en) 2000-01-26
RS49701B (sr) 2007-12-31
NO324619B1 (no) 2007-11-26
HUP0002473A2 (hu) 2000-12-28
PL190753B1 (pl) 2006-01-31
AR011773A1 (es) 2000-09-13
UA52722C2 (uk) 2003-01-15
KR100471708B1 (ko) 2005-03-07
EA199900659A1 (ru) 2000-02-28
CN1126535C (zh) 2003-11-05
CZ237499A3 (cs) 2000-01-12
LT4677B (lt) 2000-07-25
WO1998031343A2 (en) 1998-07-23
AU5495298A (en) 1998-08-07
CA2278025C (en) 2005-09-06
HUP0002473A3 (en) 2001-01-29
LV12449B (en) 2000-09-20
PL334614A1 (en) 2000-03-13
SK283164B6 (sk) 2003-03-04
AU730953B2 (en) 2001-03-22
CZ294919B6 (cs) 2005-04-13
YU36199A (sh) 2002-09-19
WO1998031343A3 (en) 1998-09-17
EA001775B1 (ru) 2001-08-27
ATE249205T1 (de) 2003-09-15
US6368616B1 (en) 2002-04-09
DE69818026T2 (de) 2004-07-08
TW503113B (en) 2002-09-21

Similar Documents

Publication Publication Date Title
ZA98303B (en) Aqueous suspension for nasal administration
GB9726916D0 (en) Nasal formulation
PL334447A1 (en) Inhaler
PL335799A1 (en) Inhaler
PL335690A1 (en) Inhaler
PL335701A1 (en) Inhaler
AU135548S (en) Inhaler
AU135120S (en) Inhaler
HU9801044D0 (en) Sulfonyl-amino-carboxylic acid derivatives
AU144047S (en) Nasal mask
US5865452C1 (en) Steerable suspension system
HK1033102A1 (en) Nose sprayer
SG76535A1 (en) Pharmaceutical agents
AU3290595A (en) An aqueous nasal suspension
GB9815532D0 (en) Pharmaceutical suspension formulation
AU144046S (en) Nasal mask
GB9719577D0 (en) Suspension systems
GB2320900B (en) Inhalers
GB2329340B (en) Breathing aid
GB9705071D0 (en) Nebuliser
GB9721597D0 (en) (Nasal) breathing aid
CA79927S (en) Nasal mask
PH30175A (en) Aqueous pharmaceutical suspension for pharmaceutical actives
GB9725519D0 (en) Nasal formulation
GB9706882D0 (en) Suspension system

Legal Events

Date Code Title Description
MM9A Lapsed patents

Effective date: 20100114